Extremity tissue expanders sales will rise through 2036, driven by breast reconstruction at a 45.0% share in 2026 as the leading application segment. The market was valued at USD 0.80 billion in 2025 and is expected to reach USD 1.37 billion by 2036, creating an incremental opportunity of USD 0.53 billion.